 | This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (August 2021) |
 | |
| Company type | Public |
|---|---|
| Nasdaq: CDXS Russell 2000 Component | |
| Industry | Protein engineering, biocatalysis, industrial enzymes, fine chemicals |
| Founded | 2002 |
| Headquarters | Redwood City, California, U.S. |
Key people | |
| Revenue |  US$68.5 million (FY 2019) |
Number of employees | 165 (as of April 2020)[1] |
| Website | codexis |
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.[2][3]
- ^ "Codexis Overview". Retrieved 2011-04-03.
- ^ "Codexis, Molecular Assemblies Ink Enzyme Engineering Collaboration Agreement". GenomeWeb. 23 June 2020. Retrieved 2021-03-12.
- ^ Hyde, Embriette (2019-09-04). "Engineering the future of biotherapeutics". SynBioBeta. Retrieved 2021-03-12.